Somerville Welcomes New Life Sciences Complex to Assembly Square

Posted by ISPE Boston
On January 22, 2021

BioMed Realty, a leading provider of real estate solutions to the life science and technology industries, has announced the acquisition of an existing 162,000 square foot office building and adjacent 7.5 acre site at Assembly Square in Somerville. The Assembly Square campus will be developed in phases and represents a total of 1.3 million square […]

Fujifilm Biotech Arm Ups Investment in Boston Area

Posted by ISPE Boston
On January 22, 2021

Fujifilm Corporation and The Massachusetts Center for Advanced Biological Innovation and Manufacturing (CABIM) have secured 76M in financing and signed a lease for a 40,000 square-foot site in Watertown at The Arsenal on the Charles. The Center will advance research and development in cell and gene therapy, gene editing, immunotherapy, and biotechnology. Fujifilm Diosynth Biotechnologies, […]

Four Local Biotechs Attract Investor Funding

Posted by ISPE Boston
On January 21, 2021

Echoing a nationwide trend, local life sciences companies continue to attract record funding as investors respond to the industry’s recent pandemic-fueled successes and heightened visibility: Since launching a year ago, Cambridge-based EQRx has raised approximately $750M including a recent $500M Series B financing to advance its mission of bringing new medicines to patients and healthcare […]

Announcing New Chapter Membership Promotion

Posted by ISPE Boston
On January 20, 2021

New Year, Time to Renew or Join! Let’s kick this year off by showing our appreciation for your continued support. As we look ahead to what we hope will be better times for all of us, we want to continue to encourage you to join ISPE Boston. Therefore, we are excited to start 2021 with […]

Dewpoint to Collaborate with Pfizer on Muscular Dystrophy

Posted by ISPE Boston
On January 14, 2021

Dewpoint Therapeutics has announced a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of myotonic dystrophy type 1 (DM1), a rare genetic disorder and one of two types of myotonic dystrophy. Under the agreement, Dewpoint will receive an upfront payment and will be eligible to receive research, development, and […]

bluebird bio to Split into Two Separate Companies

Posted by ISPE Boston
On January 14, 2021

bluebird bio has announced its intent to separate its severe genetic disease (SGD) and oncology businesses into differentiated and independent publicly traded companies. bluebird bio, Inc. will retain focus on SGD and will launch its oncology business (“Oncology Newco”) as a new entity. Upon completion of the separation, current chief bluebird, Nick Leschly, will lead Oncology […]

Agios to Sell Its Oncology Business for Up to $2 Billion

Posted by ISPE Boston
On January 14, 2021

Agios Pharmaceuticals has entered into a definitive agreement to sell its commercial, clinical and research-stage oncology portfolio to Servier, an independent global pharmaceutical company for which it will receive a cash consideration of up to $2.0 billion, including $1.8 billion in upfront cash. Agios plans to move forward with a singular focus on its genetically defined disease portfolio, including […]

A TEMPlate for the Future of Biomanufacturing

Posted by ISPE Boston
On January 13, 2021

ARMI | BioFabUSA will be offering a members-only series of technical workshops centered on advanced manufacturing technologies for Tissue Engineered Medical Products (TEMPs). In this exciting workshop series, you will hear from ARMI|BioFabUSA and its community members about the latest advancements in equipment, measurement, materials, and processes toward achieving scalable, modular, automated, and closed manufacturing for […]

Single Use Technologies – Unanswered Questions

Posted by Aaron Hubbell
On January 12, 2021

Up until a few years ago, single use technologies were pitched as “the way of the future;” a solution to high capital investments in new facilities, a way to speed equipment changeover, and a path to reduced energy and water use. Most of us would agree that single-use is no longer “the future,” but truly […]

Provide Your Feedback Here on a New Type of Chapter Program

Posted by Howard Sneider
On January 7, 2021

Though the advent of vaccines will eventually allow a return to normalcy, we still need to use protective safety measures for the foreseeable future. The associated restrictions have forced the world to adapt and learn how to do things in new ways. This includes the Boston Area Chapter and the types of programs it offers. […]

Page 54 of 118«‹52 535455 56 ›»